ISTH 2022 Congress
Diagnostics and OMICs » Laboratory Diagnostics
Theme Navigation
- ISTH 2022 Congress
- Diagnostics and OMICs
- Laboratory Diagnostics
- Diagnostics and OMICs
-
Abstract Number: PB1055
“Does my patient have HIT? There should be an app for that.”
-
Abstract Number: OC 17.3
A collaborative study to harmonize thrombin generation assays for measurement of procoagulant activity in immune globulins
-
Abstract Number: PB1086
A comparative in vitro study of the coagulation effects of branded versus generic preparations of rivaroxaban
-
Abstract Number: PB1113
A method for measuring chromogenic factor VIII activity unbiased by the presence of the bispecific antibody Emicizumab
-
Abstract Number: VPB1116
A novel material for the improvement of HIT detection
-
Abstract Number: PB1111
A novel prothrombin R533Q variant in patient with recurrent venous thrombosis
-
Abstract Number: PB1057
A novel, easy-to-use ADAMTS13 activity assay using a fiber-optic surface plasmon resonance biosensor for diagnosis of thrombotic thrombocytopenic purpura
-
Abstract Number: PB1091
A potential suitable alternative to Triton-X-100 for use in sample preparation for platelet nucleotide analysis
-
Abstract Number: PB1090
A re-visit of the Pre-Kallikrein (Fletcher trait) assay to optimise for laboratory use
-
Abstract Number: PB1063
A sensitive and user-friendly method for quantifying VWF collagen binding (VWF:CB) using a fiber optic – surface plasmon resonance biosensor
-
Abstract Number: PB1107
A specific threshold for ELISA detection of Von Willebrand alloantibodies in patients diagnosed as type 3 von Willebrand disease.
-
Abstract Number: PB1083
Accuracy Of The Hyphen Zymutest IgG ELISA Assay For Anti-Platelet Factor 4 Antibody Detection After ChAdOx1 nCov-19 Vaccination In Diagnosing Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT)
-
Abstract Number: PO0026
Activated Clotting Time : Setting Target Values of CPB when Changing from Hemochron Resopnse to i-STAT
-
Abstract Number: PB1073
Anti-Xa and APTT stability in whole blood – a comparison of UFH & LMWH
-
Abstract Number: VPB1121
Application of Next-generation sequencing in the study of inherited platelet disorders
-
Abstract Number: VPB1118
Application of prothrombin time clot waveform analysis to assessment of in vitro effects of anticoagulants on normal plasma
-
Abstract Number: PB1110
Buffy-coat-derived megakaryocytes for monoclonal antibody immobilization of platelet antigens (MAIMA) assay
-
Abstract Number: PB1097
Can Low-molecular weight heparin calibrated anti-FXa assays be used to estimate Factor Xa inhibiting Direct Oral Anticoagulant levels?
-
Abstract Number: PB1076
Clinical utility of ISTH BAT and Thromboelastography in assessment of patients referred for evaluation of bleeding disorders
-
Abstract Number: PB1096
Clot Time Ratio (CTR) in atrial fibrillation patients on rivaroxaban
- 1
- 2
- 3
- 4
- Next Page »